Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Debt Ratio (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Debt Ratio data on record, last reported at 0.38 in Q4 2025.

  • For Q4 2025, Debt Ratio rose 29.0% year-over-year to 0.38; the TTM value through Dec 2025 reached 0.38, up 29.0%, while the annual FY2025 figure was 0.38, 29.0% up from the prior year.
  • Debt Ratio reached 0.38 in Q4 2025 per MRVI's latest filing, up from 0.34 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.41 in Q3 2024 and bottomed at 0.23 in Q4 2022.
  • Average Debt Ratio over 5 years is 0.33, with a median of 0.33 recorded in 2021.
  • Peak YoY movement for Debt Ratio: tumbled 40.76% in 2022, then skyrocketed 76.3% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.39 in 2021, then crashed by 40.76% to 0.23 in 2022, then surged by 52.48% to 0.35 in 2023, then fell by 16.71% to 0.29 in 2024, then rose by 29.0% to 0.38 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.38 in Q4 2025, 0.34 in Q3 2025, and 0.32 in Q2 2025.